Features Screener Stocks Charts
Sign In Sign Up

Dishman Pharmaceuticals & Chemicals Income Statement

NSE:DISHMAN | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year DISHMAN income statement snapshot

Hover the chart icon for YoY change.

FY 2017 - FY 2018
Item Chart 2017 2018
Revenue 17.14B 16.95B
Cost of Revenue -3.29B -3.37B
Gross Profit 13.84B 13.58B
Sales, General & Admin -9.31B -9.13B
Operating Income 2.40B 2.34B
Profit Before Tax 2.17B 2.31B
Net Income 1.45B 1.55B
Diluted Shares 161.39M 161.39M
Diluted EPS 9.01 9.58

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2018